Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin versus syntocinon for prevention of postpartum haemorrhage at emergency caesarean section
ACTRN12612000466842Phase 2Not yet recruiting
- Sponsor
- Carole-anne Whigham
- Start
- Aug 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in postpartum hemorrhage (PPH) comparing Carbetocin IV with Syntocinon IV bolus (2 arms). Primary endpoint: Need for further uterotonics. Planned start Aug 2012; status: not yet recruiting.
02
Drugs
carbetocinoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ACTRN12612000466842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000466842.